Woman Learns She Has Same Disease that Took the Lives of Her Mom and Sister, Leaving Teenage Son 'Absolutely Devastated'
Holly Turner's doctors initially thought her tremors were due to stress, but they were symptoms of ALS, which also took the ...
Cognixion Launches Clinical Trial for Late-Stage ALS to Deliver Conversation Level Communication with Adaptive AI-Driven Brain-Computer Interface
The study will measure the impact of Cognixion's novel combination of BCI, AI and AR technology on the ability of amyotrophic lateral sclerosis ...
Hosted on MSN15d
Blood test could lead to better diagnosis and management of ALS
ALS, or amyotrophic lateral sclerosis, can sometimes be difficult to diagnose or ... it can help in predicting prognosis, evaluating what stage of the disease people are in, and tracking their ...
StudyFinds on MSN10d
Breakthrough blood test could transform ALS diagnosis, care
Find out about the new ALS blood test that offers accurate diagnosis and could replace traditional invasive testing methods.
LabOnline2d
Which blood test is best at monitoring ALS?
A new study compares three types of blood biomarkers: neurofilament light chain proteins, glial acidic proteins and phosphorylated tau 181.
Clene Demonstrates Strengthened ALS Survival Benefit with CNM-Au8® Treatment
Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...
Repurposed amyotrophic lateral sclerosis drug becomes imaging probe to help diagnose neurodegeneration
Positron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative ...
MassDevice1d
Cognixion launches trial of BCI device paired with AI application for people with ALS
Cognixion announced today that it launched a clinical trial evaluating its integrated, wearable augmented reality and BCI ...
QurAlis Announces Topline Data From its Phase 1 Clinical Trial of QRL-101 Evaluating Biomarkers of ALS and Epilepsy in Healthy Volunteers
QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of ...
ALS News Today6d
Tiziana seeking FDA OK to launch clinical trial of foralumab in ALS
Tiziana is seeking FDA clearance for a Phase 2 clinical trial testing the safety and efficacy of its foralumab nasal spray in ...
Tiziana: Foralumab Drug Development Presses On With Additional EAP Enrollment
Fully human intranasal foralumab shows promise in treating Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS.